Lobbying

Manus Bio's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $180K. Its first report covers Q1 2023; the issues it reports most are Manufacturing and Chemicals/Chemical Industry.

Manus Bio

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$180K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q1 2023
The first quarter a report named it

Lobbying by quarter

Manus Bio lobbying by quarter
Manus Bio lobbying by quarter
QuarterAmountReports
Q1 2023$01
Q2 2023$40K1
Q3 2023$25K1
Q4 2023$30K1
Q1 2024$01
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$20K1
Q3 2025$60K1
Q4 2025$60K1
Q1 2026$60K1
Q2 2026$60K1
Q3 2026$00

By issue

  • Manufacturing$260K · 5 reports
  • Chemicals$95K · 4 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES9 reports
  • SENATE9 reports
  • Health & Human Services, Dept of (HHS)5 reports
  • White House Office5 reports
  • Executive Office of the President (EOP)4 reports

Firms it paid

Firm
CGCN Group$260K5 quarters
Arcuri Ward$95K5 quarters

Former officials lobbying for it

Former position
ALLEN BOYDFormer Member of CongressQ4 2023
MICHAEL ARCURIFormer Member of CongressQ4 2023

Lobbying reports

Filed by
07/19for Q2CGCN Group$60K
04/20for Q1CGCN Group$60K
01/20for Q4 2025CGCN Group$60K
25/10/20for Q3 2025CGCN Group$60K
25/07/23for Q2 2025CGCN Group$20K
25/07/22for Q3 2025CGCN GroupUnder $5,000
24/04/03for Q1 2024Arcuri WardUnder $5,000
24/02/08for Q4 2023Arcuri Ward$30K
24/02/08for Q4 2023Arcuri Ward$40K
24/02/06for Q4 2023Arcuri Ward$25K
23/12/01for Q3 2023Arcuri Ward$25K
23/08/12for Q2 2023Arcuri Ward$40K
23/04/23for Q1 2023Arcuri WardUnder $5,000
23/04/21for Q1 2023Arcuri WardUnder $5,000